entity

LRRK2 G2019S

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LRRK2 G2019S: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
1Hypotheses
2Analyses
9Outgoing
0Incoming
0Experiments
2Debates

No AI portrait yet

Wiki Pages (5)

Knowledge base pages for this entity

LRRK2 G2019S

disease · 3622 words

LRRK2 G2019S Dopaminergic Neurons

cell · 659 words

iPSC-Derived LRRK2 G2019S Dopaminergic Neurons

cell · 615 words

LRRK2 G2019S Transgenic Mouse Model

model · 531 words

iPSC-Derived Dopaminergic Neurons (LRRK2 G2019S)

cell · 524 words

Outgoing (9)

TargetRelationTypeStr
Parkinson's Diseaseassociated_withdisease0.95
RAB10 hyperphosphorylationcausesmechanism0.90
endosomal trafficking defectscausesmechanism0.70
lysosomal pH elevationcausesphenotype0.70
neurite degenerationcausesphenotype0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
LRRK2 G2019S Uncouples RAB29-Dependent Spatial Control from 0.640 neurodegeneration Do pathogenic LRRK2 mutations amplify vo

Mentioning Analyses (2)

Scientific analyses that reference this entity

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

neurodegeneration | 2026-04-27 | 0 hypotheses

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

neurodegeneration | 2026-04-23 | 7 hypotheses Top: 0.780

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

active · Rounds: 6 · Score: 0.89 · 2026-04-27

The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation

closed · Rounds: 4 · Score: 0.80 · 2026-04-26

Related Research

Hypotheses and analyses mentioning LRRK2 G2019S in their description or question text

No additional research found